Using AI to improve patient access to clinical trials
Paradigm uses OpenAI’s API to improve patient access to clinical trials.
Entities: OpenAI
Paradigm uses OpenAI’s API to improve patient access to clinical trials.
Entities: OpenAI
We are releasing new models, reducing prices for GPT‑3.5 Turbo, and introducing new ways for developers to manage API keys and understand API usage. The new models include:
GPT-4 Turbo with 128K context and lower prices, the new Assistants API, GPT-4 Turbo with Vision, DALL·E 3 API, and more.
We developed a safety mitigation stack to ready DALL·E 3 for wider release and are sharing updates on our provenance research.
Entities: ChatGPTChatGPT Plus
Developer registration for in-person attendance will open in the coming weeks and developers everywhere will be able to livestream the keynote.
Entities: OpenAI
Developers can now bring their own data to customize GPT-3.5 Turbo for their use cases.
We’re announcing updates including more steerable API models, function calling capabilities, longer context, and lower prices.
Starting today, developers can begin building apps with the DALL·E API.
We are introducing a new and improved content moderation tool. The Moderation endpoint improves upon our previous content filter, and is available for free today to OpenAI API developers.
Entities: OpenAIOpenAI API
Cohere, OpenAI, and AI21 Labs have developed a preliminary set of best practices applicable to any organization developing or deploying large language models.
Entities: OpenAI
Codex is now powering 70 different applications across a variety of use cases through the OpenAI API.
Topics: Code Assistants
We’ve released new versions of GPT-3 and Codex which can edit or insert content into existing text, rather than just completing existing text.
Topics: Code Assistants
Entities: Code Assistants